EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparing Pregnancy Outcomes in Fetal Growth Restriction and Overgrowth in Women with Type 1 Diabetes: A Narrative Review

Elena Alekseenkova, Ekaterina Kopteeva, Roman Kapustin

Endocrines · 03.08.2026 · 7 (3) · 41

DOI: 10.3390/endocrines7030041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrines, online erschienen am 03.08.2026. Verfasst von Elena Alekseenkova und 2 weiteren Autor:innen. Die Arbeit nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several scenarios of abnormal fetal growth develop during pregnancy in women with pregestational diabetes. A trend towards a higher incidence of large-for-gestational-age (LGA) births among women with type 1 diabetes (T1D) is observed worldwide despite novel approaches to maternal glycaemic control. Fetal growth restriction (FGR) is commonly recognised as a severe condition. However, the risk of adverse outcomes in LGA fetuses generally remains underestimated.

Methods

We conducted a comparative analysis of pregnancy outcomes across different birthweight categories in pregnancies with T1D based on published data (2001–2026).

Results

Interactions between disorders of early placentation, impaired nutrient transfer, fetal overnutrition, and genetic background result in alterations in birthweight and disproportionate fetal adipose tissue deposition. Both FGR and macrosomia are associated with increased risks of adverse perinatal outcomes. Although stillbirth occurs at both extremes of fetal growth, term LGA fetuses may remain particularly vulnerable because routine surveillance methods, including arterial Doppler assessment, fail to identify compromised fetuses with excessive growth. Accelerated fetal growth in T1D pregnancies, when placentation is initially impaired, may cause growth-restricted fetuses to appear appropriate for gestational age (AGA). Routine assessment may classify these vulnerable fetuses as being at low risk of perinatal complications. Disproportionate growth, even among infants classified as AGA, is associated with shoulder dystocia, birth trauma, and operative delivery. Neonatal hypoglycaemia and respiratory disorders remain frequent complications across the spectrum of abnormal fetal growth.

Conclusions

Increased glucose variability may explain differences in placental and fetal growth trajectories and the high rate of pregnancy complications in patients with target glycated haemoglobin levels and routine capillary glucose monitoring results. Fetal overgrowth reflects impaired intrauterine development and should be considered a high-risk condition requiring careful consideration of the timing and mode of delivery.

Zitieren

APA

Alekseenkova, E., Kopteeva, E., & Kapustin, R. (2026). Comparing Pregnancy Outcomes in Fetal Growth Restriction and Overgrowth in Women with Type 1 Diabetes: A Narrative Review. Endocrines, 7(3), 41. https://doi.org/10.3390/endocrines7030041

Vancouver

Alekseenkova E, Kopteeva E, Kapustin R. Comparing Pregnancy Outcomes in Fetal Growth Restriction and Overgrowth in Women with Type 1 Diabetes: A Narrative Review. Endocrines. 2026;7(3):41. doi:10.3390/endocrines7030041

BibTeX
@article{Alekseenkova2026,
  author = {Alekseenkova, Elena and Kopteeva, Ekaterina and Kapustin, Roman},
  title = {Comparing Pregnancy Outcomes in Fetal Growth Restriction and Overgrowth in Women with Type 1 Diabetes: A Narrative Review},
  journal = {Endocrines},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {41},
  doi = {10.3390/endocrines7030041}
}
Kostenlos starten →